To the best of our knowledge, this is the first study to detail the EPA inhibition mechanisms of KLK2, KLK4, KLK6, and KLK14 gene activities, consequently prohibiting PCa cell proliferation. The gene discussed is KLK14; the disease is posterior cortical atrophy.